Plasma n-3 and n-6 fatty acids are differentially related to carotid plaque and its progression: The multi-ethnic study of atherosclerosis

Brian T. Steffen, Weihua Guan, James H. Stein, Mathew C. Tattersall, Joel D. Kaufman, Veit Sandfort, Moyses Szklo, Michael Y. Tsai

Research output: Contribution to journalArticle

Abstract

Objective-ω-3 (n-3) fatty acids (FAs) have long been considered healthful dietary components, yet recent clinical trials have questioned their cardiovascular benefits. By contrast, the ω-6 (n-6) FAs have been considered harmful, proatherogenic macronutrients, despite an absence of empirical evidence supporting this hypothesis. We aimed to determine whether plasma n-3 and n-6 FAs are related to risk of carotid plaque and its progression in 3327 participants of MESA (Multi- Ethnic Study of Atherosclerosis). Approach and Results-Carotid plaque was assessed using ultrasonography at baseline and after a median period of 9.5 years. Plasma phospholipid n-3 and n-6 FAs were determined using gas chromatography-flame ionization detection. Relative risk regression analyses assessed the relations of FAs with the presence or progression of carotid plaque adjusted for typical cardiovascular disease risk factors. At baseline, it was found that participants in the fourth quartile of n-3 docosahexaenoic acid showed a 9% lower risk of carotid plaque (P=0.05), whereas those in the second quartile of n-3 α- linolenic acid showed an 11% greater risk compared with respective referent quartiles (P=0.02). In prospective analyses, individuals in the top quartile of docosahexaenoic acid showed a 12% lower risk of carotid plaque progression during 9.5 years compared with those in the referent quartile (P=0.002). No significant relations were observed among n-6 FAs and plaque outcomes. No significant race/ethnicity interactions were found. Conclusions-These findings support docosahexaenoic acid as an atheroprotective macronutrient, whereas null findings for n-6 FAs challenge the view that they promote atherosclerosis.

Original languageEnglish (US)
Pages (from-to)653-659
Number of pages7
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume38
Issue number3
DOIs
StatePublished - Jan 1 2018

Fingerprint

Atherosclerosis
Fatty Acids
Docosahexaenoic Acids
Flame Ionization
alpha-Linolenic Acid
Omega-3 Fatty Acids
Gas Chromatography
Ultrasonography
Phospholipids
Cardiovascular Diseases
Regression Analysis
Clinical Trials

Keywords

  • Atherosclerosis
  • Fatty acids
  • Humans
  • Prospective studies
  • Risk factors

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Plasma n-3 and n-6 fatty acids are differentially related to carotid plaque and its progression : The multi-ethnic study of atherosclerosis. / Steffen, Brian T.; Guan, Weihua; Stein, James H.; Tattersall, Mathew C.; Kaufman, Joel D.; Sandfort, Veit; Szklo, Moyses; Tsai, Michael Y.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 38, No. 3, 01.01.2018, p. 653-659.

Research output: Contribution to journalArticle

Steffen, Brian T. ; Guan, Weihua ; Stein, James H. ; Tattersall, Mathew C. ; Kaufman, Joel D. ; Sandfort, Veit ; Szklo, Moyses ; Tsai, Michael Y. / Plasma n-3 and n-6 fatty acids are differentially related to carotid plaque and its progression : The multi-ethnic study of atherosclerosis. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 2018 ; Vol. 38, No. 3. pp. 653-659.
@article{352aafbd87e14e5591b4379efd8e9806,
title = "Plasma n-3 and n-6 fatty acids are differentially related to carotid plaque and its progression: The multi-ethnic study of atherosclerosis",
abstract = "Objective-ω-3 (n-3) fatty acids (FAs) have long been considered healthful dietary components, yet recent clinical trials have questioned their cardiovascular benefits. By contrast, the ω-6 (n-6) FAs have been considered harmful, proatherogenic macronutrients, despite an absence of empirical evidence supporting this hypothesis. We aimed to determine whether plasma n-3 and n-6 FAs are related to risk of carotid plaque and its progression in 3327 participants of MESA (Multi- Ethnic Study of Atherosclerosis). Approach and Results-Carotid plaque was assessed using ultrasonography at baseline and after a median period of 9.5 years. Plasma phospholipid n-3 and n-6 FAs were determined using gas chromatography-flame ionization detection. Relative risk regression analyses assessed the relations of FAs with the presence or progression of carotid plaque adjusted for typical cardiovascular disease risk factors. At baseline, it was found that participants in the fourth quartile of n-3 docosahexaenoic acid showed a 9{\%} lower risk of carotid plaque (P=0.05), whereas those in the second quartile of n-3 α- linolenic acid showed an 11{\%} greater risk compared with respective referent quartiles (P=0.02). In prospective analyses, individuals in the top quartile of docosahexaenoic acid showed a 12{\%} lower risk of carotid plaque progression during 9.5 years compared with those in the referent quartile (P=0.002). No significant relations were observed among n-6 FAs and plaque outcomes. No significant race/ethnicity interactions were found. Conclusions-These findings support docosahexaenoic acid as an atheroprotective macronutrient, whereas null findings for n-6 FAs challenge the view that they promote atherosclerosis.",
keywords = "Atherosclerosis, Fatty acids, Humans, Prospective studies, Risk factors",
author = "Steffen, {Brian T.} and Weihua Guan and Stein, {James H.} and Tattersall, {Mathew C.} and Kaufman, {Joel D.} and Veit Sandfort and Moyses Szklo and Tsai, {Michael Y.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1161/ATVBAHA.117.310366",
language = "English (US)",
volume = "38",
pages = "653--659",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Plasma n-3 and n-6 fatty acids are differentially related to carotid plaque and its progression

T2 - The multi-ethnic study of atherosclerosis

AU - Steffen, Brian T.

AU - Guan, Weihua

AU - Stein, James H.

AU - Tattersall, Mathew C.

AU - Kaufman, Joel D.

AU - Sandfort, Veit

AU - Szklo, Moyses

AU - Tsai, Michael Y.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective-ω-3 (n-3) fatty acids (FAs) have long been considered healthful dietary components, yet recent clinical trials have questioned their cardiovascular benefits. By contrast, the ω-6 (n-6) FAs have been considered harmful, proatherogenic macronutrients, despite an absence of empirical evidence supporting this hypothesis. We aimed to determine whether plasma n-3 and n-6 FAs are related to risk of carotid plaque and its progression in 3327 participants of MESA (Multi- Ethnic Study of Atherosclerosis). Approach and Results-Carotid plaque was assessed using ultrasonography at baseline and after a median period of 9.5 years. Plasma phospholipid n-3 and n-6 FAs were determined using gas chromatography-flame ionization detection. Relative risk regression analyses assessed the relations of FAs with the presence or progression of carotid plaque adjusted for typical cardiovascular disease risk factors. At baseline, it was found that participants in the fourth quartile of n-3 docosahexaenoic acid showed a 9% lower risk of carotid plaque (P=0.05), whereas those in the second quartile of n-3 α- linolenic acid showed an 11% greater risk compared with respective referent quartiles (P=0.02). In prospective analyses, individuals in the top quartile of docosahexaenoic acid showed a 12% lower risk of carotid plaque progression during 9.5 years compared with those in the referent quartile (P=0.002). No significant relations were observed among n-6 FAs and plaque outcomes. No significant race/ethnicity interactions were found. Conclusions-These findings support docosahexaenoic acid as an atheroprotective macronutrient, whereas null findings for n-6 FAs challenge the view that they promote atherosclerosis.

AB - Objective-ω-3 (n-3) fatty acids (FAs) have long been considered healthful dietary components, yet recent clinical trials have questioned their cardiovascular benefits. By contrast, the ω-6 (n-6) FAs have been considered harmful, proatherogenic macronutrients, despite an absence of empirical evidence supporting this hypothesis. We aimed to determine whether plasma n-3 and n-6 FAs are related to risk of carotid plaque and its progression in 3327 participants of MESA (Multi- Ethnic Study of Atherosclerosis). Approach and Results-Carotid plaque was assessed using ultrasonography at baseline and after a median period of 9.5 years. Plasma phospholipid n-3 and n-6 FAs were determined using gas chromatography-flame ionization detection. Relative risk regression analyses assessed the relations of FAs with the presence or progression of carotid plaque adjusted for typical cardiovascular disease risk factors. At baseline, it was found that participants in the fourth quartile of n-3 docosahexaenoic acid showed a 9% lower risk of carotid plaque (P=0.05), whereas those in the second quartile of n-3 α- linolenic acid showed an 11% greater risk compared with respective referent quartiles (P=0.02). In prospective analyses, individuals in the top quartile of docosahexaenoic acid showed a 12% lower risk of carotid plaque progression during 9.5 years compared with those in the referent quartile (P=0.002). No significant relations were observed among n-6 FAs and plaque outcomes. No significant race/ethnicity interactions were found. Conclusions-These findings support docosahexaenoic acid as an atheroprotective macronutrient, whereas null findings for n-6 FAs challenge the view that they promote atherosclerosis.

KW - Atherosclerosis

KW - Fatty acids

KW - Humans

KW - Prospective studies

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=85047940663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047940663&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.117.310366

DO - 10.1161/ATVBAHA.117.310366

M3 - Article

C2 - 29326315

AN - SCOPUS:85047940663

VL - 38

SP - 653

EP - 659

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 3

ER -